AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33269876 — intervention group
Group type: COMPARATOR
Intervention: Usual Care Control
Number of subjects: 52
Study 32717123 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise intervention
Number of subjects: 24
Study 36189993 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 IU/kg NM57
Number of subjects: 60
Study 36189993 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 IU/kg NM57
Number of subjects: 60
Study 36189993 — intervention group
Group type: COMPARATOR
Intervention: 20 IU/kg HRIG
Number of subjects: 60
Study 32240476 — intervention group
Group type: EXPERIMENTAL
Intervention: MDGP external umbilicus treatment, twice a week for 4 weeks.
Number of subjects: 72
Study 32240476 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group, twice a week for 4 weeks.
Number of subjects: 72
Study 32167484 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg daily for 8 weeks before HoLEP
Number of subjects: 402
Study 33150816 — intervention group
Group type: EXPERIMENTAL
Intervention: SHP465 mixed amphetamine salts (MAS) extended-release
Number of subjects: 0
Study 33150816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32981933 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic drink (fermented milk containing Lactobacillus casei strain Shirota) 65 mL/day with 108 CFU/mL for 12 weeks
Number of subjects: 1003
Study 32981933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic intervention)
Number of subjects: 1003
Study 36074775 — intervention group
Group type: EXPERIMENTAL
Intervention: PACTS (patient-delivered household contact tracing and prevention for tuberculosis)
Number of subjects: 214
Study 36074775 — intervention group
Group type: EXPERIMENTAL
Intervention: PACTS
Number of subjects: 214
Study 36074775 — intervention group
Group type: COMPARATOR
Intervention: SOC (standard of care)
Number of subjects: 214
Study 36074775 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 214
Study 33914402 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Comorbidity Index (TCI)
Number of subjects: 84903
Study 33914402 — intervention group
Group type: COMPARATOR
Intervention: Charlson and Elixhauser comorbidity indices
Number of subjects: 84903
Study 34872390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention with poetry (G1) - reading a booklet about values and principles of professional ethics and poems for 1 month
Number of subjects: 108
Study 34872390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention without poetry (G2) - reading the booklet without poetry
Number of subjects: 108
Study 34872390 — intervention group
Group type: COMPARATOR
Intervention: Control group (G3) - no intervention
Number of subjects: 108
Study 32946821 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 251
Study 32946821 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 251
Study 32946821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 36157386 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised exercise training using ventilatory thresholds
Number of subjects: 38
Study 36157386 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised exercise training using a percentage of heart rate reserve
Number of subjects: 38
Study 36157386 — intervention group
Group type: COMPARATOR
Intervention: Control group (convenience sample)
Number of subjects: 38
Study 32339234 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing and tailored counselling on medication adherence
Number of subjects: 1009
Study 32339234 — intervention group
Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 1009
Study 35637458 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck-specific exercises (NSE)
Number of subjects: 20
Study 35637458 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-supported neck-specific exercises (NSEIT)
Number of subjects: 20
Study 35637458 — intervention group
Group type: EXPERIMENTAL
Intervention: NSEIT and NSE
Number of subjects: 20
Study 35637458 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapists' self-efficacy and confidence in diagnosing and treating patients with neck pain
Number of subjects: 20
Study 34485522 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacophore model AAARRR.1061
Number of subjects: 62
Study 34485522 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular docking analysis of compound STOCK2S-23597
Number of subjects: 62
Study 36233791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavior Therapy delivered by Videoconference (VCP)
Number of subjects: 148
Study 36233791 — intervention group
Group type: COMPARATOR
Intervention: Face-to-Face Cognitive-Behavior Therapy
Number of subjects: 148
Study 36233791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavior Therapy (both VCP and Face-to-Face)
Number of subjects: 148
Study 34619419 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercises
Number of subjects: 84
Study 34619419 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing interventions
Number of subjects: 84
Study 34000628 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged release-fampridine (10 mg b.i.d.)
Number of subjects: 39
Study 34000628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33770278 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 + 1 technique (bipolar electrocoagulation catheter)
Number of subjects: 148
Study 33770278 — intervention group
Group type: COMPARATOR
Intervention: Direct-stroke technique (bipolar electrocoagulation catheter)
Number of subjects: 148
Study 34545448 — intervention group
Group type: EXPERIMENTAL
Intervention: Venovo venous stent
Number of subjects: 170
Study 34050763 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation with lifestyle modifications
Number of subjects: 0
Study 34050763 — intervention group
Group type: COMPARATOR
Intervention: Placebo with lifestyle modifications
Number of subjects: 0
Study 33234137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment with ticagrelor
Number of subjects: 2520
Study 33234137 — intervention group
Group type: EXPERIMENTAL
Intervention: Downstream administration of prasugrel
Number of subjects: 2520
Study 33234137 — intervention group
Group type: EXPERIMENTAL
Intervention: Downstream administration of ticagrelor
Number of subjects: 2520
Study 33234137 — intervention group
Group type: COMPARATOR
Intervention: No pretreatment (control group)
Number of subjects: 2520
Study 36429386 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual environment practice
Number of subjects: 22
Study 36429386 — intervention group
Group type: COMPARATOR
Intervention: Real environment practice
Number of subjects: 22
Study 32416251 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpelisib plus fulvestrant
Number of subjects: 571
Study 32416251 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive anti-rash medication
Number of subjects: 571
Study 32416251 — intervention group
Group type: EXPERIMENTAL
Intervention: More-detailed AE management guidelines
Number of subjects: 571
Study 32416251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study 34260650 — intervention group
Group type: EXPERIMENTAL
Intervention: ELO water
Number of subjects: 150
Study 34260650 — intervention group
Group type: COMPARATOR
Intervention: Control water (tap water)
Number of subjects: 150
Study 32237060 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergy everolimus-eluting stents (EES)
Number of subjects: 783
Study 32237060 — intervention group
Group type: COMPARATOR
Intervention: Resolute Integrity zotarolimus-eluting stents (ZES)
Number of subjects: 783
Study 32237060 — intervention group
Group type: EXPERIMENTAL
Intervention: Orsiro sirolimus-eluting stents (SES)
Number of subjects: 783
Study 33527886 — intervention group
Group type: EXPERIMENTAL
Intervention: e-CTA (Brainomix)
Number of subjects: 301
Study 33527886 — intervention group
Group type: COMPARATOR
Intervention: Physicians (neuroradiologist, radiology resident, two neurology residents)
Number of subjects: 301
Study 34152012 — intervention group
Group type: EXPERIMENTAL
Intervention: Salpingectomy
Number of subjects: 4040
Study 34152012 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysterectomy
Number of subjects: 4040
Study 34152012 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubal ligation
Number of subjects: 4040
Study 33087054 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) received a 16-hour educational workshop on the Brazilian Dietary Guidelines (BDG)
Number of subjects: 24
Study 33087054 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study 35834812 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 μg HPV‐6/11 vaccine
Number of subjects: 145
Study 35834812 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 μg HPV‐6/11 vaccine
Number of subjects: 145
Study 35834812 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 μg HPV‐6/11 vaccine
Number of subjects: 145
Study 35834812 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 145
Study 35834812 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐6/11 vaccine (all doses)
Number of subjects: 145
Study 35834812 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐6/11 vaccine
Number of subjects: 145
Study 33028649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ironbark group-based fall prevention programme
Number of subjects: 0
Study 33028649 — intervention group
Group type: COMPARATOR
Intervention: Group-based social programme (Control)
Number of subjects: 0
Study 33774140 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0
Study 33774140 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 35319270 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 74
Study 35319270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 35319270 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (OLE)
Number of subjects: 74
Study 35319270 — intervention group
Group type: COMPARATOR
Intervention: Placebo (OLE)
Number of subjects: 74
Study 35319270 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly enrolled patients (OLE)
Number of subjects: 74
Study 33809062 — intervention group
Group type: EXPERIMENTAL
Intervention: LMF-HSFx
Number of subjects: 42
Study 35241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for low-pain procedures
Number of subjects: 912121
Study 35241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for moderate-pain procedures
Number of subjects: 912121
Study 35241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for high-pain procedures
Number of subjects: 912121
Study 35241271 — intervention group
Group type: COMPARATOR
Intervention: Sustained opioid use (4-90 days postprocedure)
Number of subjects: 912121
Study 32921508 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure with magnetic beads for 14 days
Number of subjects: 47
Study 32921508 — intervention group
Group type: COMPARATOR
Intervention: Blank patches (Control)
Number of subjects: 47
Study 36469808 — intervention group
Group type: EXPERIMENTAL
Intervention: WiseApp intervention
Number of subjects: 200
Study 36469808 — intervention group
Group type: COMPARATOR
Intervention: Attention control intervention
Number of subjects: 200
Study 36469808 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 200
Study 33854301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus before induction, followed by 2.0 mg/kg/h until end of operation)
Number of subjects: 70
Study 33854301 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 70
Study 35896015 — intervention group
Group type: EXPERIMENTAL
Intervention: Video consultation (telemedicine group)
Number of subjects: 60
Study 35896015 — intervention group
Group type: COMPARATOR
Intervention: In-person consultation (control group)
Number of subjects: 60
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician burden ratings
Number of subjects: 585
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical impressions (trust in pain report, medical attribution)
Number of subjects: 585
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: Management concerns (opioid abuse risk)
Number of subjects: 585
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: High medical evidence
Number of subjects: 585
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher pain severity
Number of subjects: 585
Study 33989786 — intervention group
Group type: EXPERIMENTAL
Intervention: Burden ratings
Number of subjects: 585
Study 32162816 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 98
Study 32162816 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 98
Study 35346274 — intervention group
Group type: EXPERIMENTAL
Intervention: Interlaminar full-endoscopic discectomy
Number of subjects: 100
Study 35346274 — intervention group
Group type: COMPARATOR
Intervention: Conventional microscopic discectomy
Number of subjects: 100
Study 33764005 — intervention group
Group type: EXPERIMENTAL
Intervention: Coming back to existence caring model
Number of subjects: 66
Study 32865010 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC, 4 × 5-min 220-mmHg unilateral occlusion at the thigh muscle)
Number of subjects: 15
Study 32865010 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 15
Study 32865010 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (sham, 4 × 5 min 20-mmHg)
Number of subjects: 15
Study 34851799 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg subcutaneously
Number of subjects: 212
Study 34851799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease risk information
Number of subjects: 282
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: Myth busting information
Number of subjects: 282
Study 32664369 — intervention group
Group type: COMPARATOR
Intervention: Control information
Number of subjects: 282
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB constructs (Attitudes)
Number of subjects: 282
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB constructs (Subjective norms)
Number of subjects: 282
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB constructs (Perceived behavioural control)
Number of subjects: 282
Study 32664369 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB constructs overall
Number of subjects: 282
Study 36476354 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 156
Study 36476354 — intervention group
Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 156
Study 36476354 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 156
Study 32914403 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional echocardiography (3DE)
Number of subjects: 85
Study 32914403 — intervention group
Group type: COMPARATOR
Intervention: Cardiac magnetic resonance (CMR)
Number of subjects: 85
Study 33084901 — intervention group
Group type: EXPERIMENTAL
Intervention: Wingman-Connect program
Number of subjects: 1485
Study 33084901 — intervention group
Group type: COMPARATOR
Intervention: Stress management program
Number of subjects: 1485
Study 35436816 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rivaroxaban (10mg or 15mg)
Number of subjects: 230
Study 35436816 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous enoxaparin (40mg or 60mg)
Number of subjects: 230
Study 34166841 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (Eligard)
Number of subjects: 150
Study 34166841 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35430239 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized 3D printed pillbox
Number of subjects: 15
Study 35430239 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized off‐the‐shelf pillbox
Number of subjects: 15
Study 35430239 — intervention group
Group type: COMPARATOR
Intervention: Standard‐of‐care pillbox
Number of subjects: 15
Study 33838763 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet self-efficacy
Number of subjects: 166
Study 33838763 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher stress
Number of subjects: 166
Study 33962340 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm IVRA
Number of subjects: 280
Study 33962340 — intervention group
Group type: COMPARATOR
Intervention: Upper arm IVRA
Number of subjects: 280
Study 32143221 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (mCIMT)
Number of subjects: 24
Study 35533340 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab (0.8 mg/kg every 2 weeks)
Number of subjects: 61
Study 35533340 — intervention group
Group type: COMPARATOR
Intervention: Pi/D (conventional therapy)
Number of subjects: 61
Study 32948386 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacomechanical catheter‐directed thrombolysis (PCDT)
Number of subjects: 317
Study 35409861 — intervention group
Group type: COMPARATOR
Intervention: Postoperative co-amoxiclav (625 mg)
Number of subjects: 46
Study 35409861 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative co-amoxiclav (625 mg) plus postoperative metronidazole (500 mg)
Number of subjects: 46
Study 35409861 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative co-amoxiclav (625 mg) plus postoperative amoxicillin (500 mg)
Number of subjects: 46
Study 35409861 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 46
Study 33795621 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory intervention for laparoscopic cholecystectomy and radical gastrectomy
Number of subjects: 0
Study 33795621 — intervention group
Group type: EXPERIMENTAL
Intervention: Both auditory and visual stimulation for colon cancer patients
Number of subjects: 0
Study 33795621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no auditory or visual intervention)
Number of subjects: 0
Study 32869472 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan with whole raw soybean (WRS)
Number of subjects: 4
Study 35781804 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE 2.0 g/day (1×1 g twice daily) for 28 days
Number of subjects: 24
Study 35781804 — intervention group
Group type: EXPERIMENTAL
Intervention: IPE 4.0 g/day (2×1 g twice daily) for 28 days
Number of subjects: 24
Study 32968914 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloshield
Number of subjects: 22
Study 32968914 — intervention group
Group type: COMPARATOR
Intervention: Control (without Coloshield)
Number of subjects: 22
Study 35510617 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% fluoride varnish applied in test group
Number of subjects: 42
Study 35510617 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water) applied in control group
Number of subjects: 42
Study 32930104 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocele repair in TA group
Number of subjects: 141
Study 32930104 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocele repair in NTA group
Number of subjects: 141
Study 32930104 — intervention group
Group type: COMPARATOR
Intervention: Comparison of TA and NTA groups
Number of subjects: 141
Study 32930104 — intervention group
Group type: COMPARATOR
Intervention: Total motile count (TMC) and DFI in NTA group
Number of subjects: 141
Study 34167878 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 129
Study 34167878 — intervention group
Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 129
Study 33840803 — intervention group
Group type: EXPERIMENTAL
Intervention: True tDCS
Number of subjects: 60
Study 33840803 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 60
Study 34578893 — intervention group
Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 768
Study 34578893 — intervention group
Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg plus a tailored lifestyle intervention program
Number of subjects: 768
Study 33518733 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatfoot group at slow, normal, and fast gait speeds
Number of subjects: 60
Study 33518733 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatfoot group at slow speed
Number of subjects: 60
Study 33518733 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatfoot group at fast speed
Number of subjects: 60
Study 33518733 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups at different gait speeds
Number of subjects: 60
Study 33518733 — intervention group
Group type: COMPARATOR
Intervention: Normal foot posture group at slow, normal, and fast gait speeds
Number of subjects: 60
Study 34119426 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral supraclavicular approach
Number of subjects: 180
Study 34119426 — intervention group
Group type: COMPARATOR
Intervention: Conventional transcervical approach
Number of subjects: 180
Study 34119426 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study 32798079 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 50
Study 32798079 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 50
Study 35788069 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin supplementation
Number of subjects: 70
Study 35788069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 34280356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 UI by mouth once a week)
Number of subjects: 73
Study 34280356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 32738817 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment for stress urinary incontinence
Number of subjects: 384
Study 34581002 — intervention group
Group type: COMPARATOR
Intervention: MTPS9579A (dissociating anti-tryptase antibody) administered subcutaneously (s.c.) or intravenously (i.v.) in single and multiple ascending doses.
Number of subjects: 106